Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CuttingEdge Bio who wrote (3240)	2/10/2021 12:16:41 AM
From: Biotechwantabe	Read Replies (2) of 3557

Well regeneron will get plenty of opportunity in row starting with Evkeeza. We always blame the partners but it’s regeneron that responsible for making a bad deal. Hopefully they hire some good global sales execs. Libtayo cemo will be the big test. Too bad Roche can’t buy out sanofi

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next